Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1959 2
1960 1
1961 1
1962 1
1963 4
1964 2
1965 3
1966 1
1967 1
1968 2
1970 2
1971 2
1972 1
1973 2
1974 5
1975 2
1976 6
1977 4
1978 3
1979 6
1980 9
1981 10
1982 6
1983 9
1984 12
1985 12
1986 14
1987 19
1988 14
1989 14
1990 23
1991 21
1992 37
1993 30
1994 22
1995 41
1996 27
1997 57
1998 44
1999 46
2000 41
2001 55
2002 52
2003 61
2004 62
2005 74
2006 81
2007 84
2008 83
2009 83
2010 126
2011 147
2012 124
2013 134
2014 143
2015 166
2016 170
2017 197
2018 200
2019 210
2020 229
2021 311
2022 419
2023 328
2024 192

Text availability

Article attribute

Article type

Publication date

Search Results

3,942 results

Results by year

Filters applied: . Clear all
Page 1
COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals.
Faksova K, Walsh D, Jiang Y, Griffin J, Phillips A, Gentile A, Kwong JC, Macartney K, Naus M, Grange Z, Escolano S, Sepulveda G, Shetty A, Pillsbury A, Sullivan C, Naveed Z, Janjua NZ, Giglio N, Perälä J, Nasreen S, Gidding H, Hovi P, Vo T, Cui F, Deng L, Cullen L, Artama M, Lu H, Clothier HJ, Batty K, Paynter J, Petousis-Harris H, Buttery J, Black S, Hviid A. Faksova K, et al. Vaccine. 2024 Apr 2;42(9):2200-2211. doi: 10.1016/j.vaccine.2024.01.100. Epub 2024 Feb 12. Vaccine. 2024. PMID: 38350768 Free article.
In total, 183,559,462 doses of BNT162b2, 36,178,442 doses of mRNA-1273, and 23,093,399 doses of ChAdOx1 were administered across participating sites in the study period. Risk periods following homologous vaccination schedules contributed 23,168,335 person-years of f …
In total, 183,559,462 doses of BNT162b2, 36,178,442 doses of mRNA-1273, and 23,093,399 doses of ChAdOx1 were administered across participati …
COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis.
Ceban F, Kulzhabayeva D, Rodrigues NB, Di Vincenzo JD, Gill H, Subramaniapillai M, Lui LMW, Cao B, Mansur RB, Ho RC, Burke MJ, Rhee TG, Rosenblat JD, McIntyre RS. Ceban F, et al. Brain Behav Immun. 2023 Jul;111:211-229. doi: 10.1016/j.bbi.2023.03.022. Epub 2023 Mar 27. Brain Behav Immun. 2023. PMID: 36990297 Free PMC article. Review.
The evidence herein supports SARS-CoV-2 vaccination for the prevention of long COVID, and recommends long COVID patients adhere to standard SARS-CoV-2 vaccination schedules....
The evidence herein supports SARS-CoV-2 vaccination for the prevention of long COVID, and recommends long COVID patients adhere to standard …
Infection and co-infection patterns of community-acquired pneumonia in patients of different ages in China from 2009 to 2020: a national surveillance study.
Liu YN, Zhang YF, Xu Q, Qiu Y, Lu QB, Wang T, Zhang XA, Lin SH, Lv CL, Jiang BG, Li H, Li ZJ, Gao GF, Yang WZ, Hay SI, Wang LP, Fang LQ, Liu W; Chinese Center for Disease Control and Prevention Etiology Surveillance Study Team of Acute Respiratory Infections. Liu YN, et al. Lancet Microbe. 2023 May;4(5):e330-e339. doi: 10.1016/S2666-5247(23)00031-9. Epub 2023 Mar 28. Lancet Microbe. 2023. PMID: 37001538 Free article.
These findings suggest potential advantages to age-related strategies for vaccine schedules, as well as clinical diagnosis, treatment, and therapy. ...
These findings suggest potential advantages to age-related strategies for vaccine schedules, as well as clinical diagnosis, tr …
Vaccine co-administration in adults: An effective way to improve vaccination coverage.
Bonanni P, Steffen R, Schelling J, Balaisyte-Jazone L, Posiuniene I, Zatoński M, Van Damme P. Bonanni P, et al. Hum Vaccin Immunother. 2023 Dec 31;19(1):2195786. doi: 10.1080/21645515.2023.2195786. Epub 2023 Apr 11. Hum Vaccin Immunother. 2023. PMID: 37039318 Free PMC article. Review.
Healthcare providers could more often recommend and practice vaccine co-administration; this would not risk patient safety and health, would improve protection against vaccine-preventable diseases, and would help comply with national vaccination calendars. Recommending bodies may …
Healthcare providers could more often recommend and practice vaccine co-administration; this would not risk patient safety and health, would …
Diphtheria.
Lamichhane A, Radhakrishnan S. Lamichhane A, et al. 2024 Feb 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2024 Feb 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 32809746 Free Books & Documents.
In prevention, vaccination against diphtheria is incorporated into the routine vaccination schedule as part of the combination diphtheria, tetanus toxoid, and acellular pertussis vaccine (DTaP). ...
In prevention, vaccination against diphtheria is incorporated into the routine vaccination schedule as part of the combination …
Vaccine schedule recommendations and updates for patients with hematologic malignancy post-hematopoietic cell transplant or CAR T-cell therapy.
Reynolds G, Hall VG, Teh BW. Reynolds G, et al. Transpl Infect Dis. 2023 Nov;25 Suppl 1(Suppl 1):e14109. doi: 10.1111/tid.14109. Epub 2023 Jul 29. Transpl Infect Dis. 2023. PMID: 37515788 Free PMC article. Review.
This review synthesizes national, international, and expert consensus vaccination schedules post-HCT and presents evidence regarding the efficacy of newer vaccine formulations for pneumococcus, recombinant zoster vaccine, and coronavirus disease 2019 in patients wit …
This review synthesizes national, international, and expert consensus vaccination schedules post-HCT and presents evidence reg …
Lessons from SENCOVAC: a prospective study evaluating the response to SARS-CoV-2 vaccination in the CKD spectrum.
Quiroga B, Soler MJ, Ortiz A, Sequera P; SENCOVAC collaborative network. Quiroga B, et al. Nefrologia. 2022 Dec 16. doi: 10.1016/j.nefro.2022.12.006. Online ahead of print. Nefrologia. 2022. PMID: 36540904 Free PMC article. Review.
However, kidney transplant recipients presented suboptimal responses after any vaccination schedule (initial, third and fourth dose). Especially worrisome is the situation of a patients with a persistently negative humoral response that do not seroconvert after boos …
However, kidney transplant recipients presented suboptimal responses after any vaccination schedule (initial, third and fourth …
A phase 3, multicenter, randomized, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants (PNEU-PED).
Lupinacci R, Rupp R, Wittawatmongkol O, Jones J, Quinones J, Ulukol B, Dagan R, Richmond P, Stek JE, Romero L, Koseoglu S, Tamms G, McFetridge R, Li J, Cheon K, Musey L, Banniettis N, Bickham K; V114-029 PNEU-PED study group. Lupinacci R, et al. Vaccine. 2023 Jan 27;41(5):1142-1152. doi: 10.1016/j.vaccine.2022.12.054. Epub 2023 Jan 6. Vaccine. 2023. PMID: 36621410 Free article. Clinical Trial.
These results support use of V114 for prevention of PD as part of routine infant vaccination schedules. TRIAL REGISTRATION: ClinicalTrials.gov: NCT03893448; EudraCT: 2018-004109-21....
These results support use of V114 for prevention of PD as part of routine infant vaccination schedules. TRIAL REGISTRATION: Cl …
Impact of influenza, herpes zoster, and pneumococcal vaccinations on the incidence of cardiovascular events in subjects aged over 65 years: a systematic review.
Addario A, Célarier T, Bongue B, Barth N, Gavazzi G, Botelho-Nevers E. Addario A, et al. Geroscience. 2023 Dec;45(6):3419-3447. doi: 10.1007/s11357-023-00807-4. Epub 2023 Jun 3. Geroscience. 2023. PMID: 37269492 Free PMC article. Review.
However, the impact of PCV13 on cardiovascular events has not been studied, nor has the currently recommended vaccination schedule (PCV13 + PPV23). As for herpes zoster vaccination, only the protective effect against stroke has been studied with the live attenuated …
However, the impact of PCV13 on cardiovascular events has not been studied, nor has the currently recommended vaccination schedule …
[Vaccination of seniors].
[No authors listed] [No authors listed] Rev Prat. 2024 Mar;74(3):Yves-Buisson. Rev Prat. 2024. PMID: 38551858 French.
VACCINATION OF SENIORS. In France, the vaccination schedule for seniors (people aged 65 and over) recommends 4 vaccinations (Covid-19, flu, DTP [diphtheria, tetanus, poliomyelitis] and shingles), plus 3 others in the event of a particular risk (pneumococcus, whoopin …
VACCINATION OF SENIORS. In France, the vaccination schedule for seniors (people aged 65 and over) recommends 4 vaccinations (C …
3,942 results